Expression profiling of blood samples from an SU5416 phase III metastatic colorectal cancer clinical trial: A novel strategy for biomarker identification

BMC Cancer

Volumn 3, Issue , 2003, Pages

  DePrimo, Samuel E ^a   Wong, Lily M ^a   Khatry, Deepak B ^a   Nicholas, Susan L ^a   Manning, William C ^a   Smolich, Beverly D ^a   O'Farrell, Anne Marie ^a   Cherrington, Julie M ^a  

^a SUGEN INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; CD24 ANTIGEN; CREMOPHOR; DEXAMETHASONE; FLUOROURACIL; FOLINIC ACID; GELATINASE B; HISTAMINE H1 RECEPTOR ANTAGONIST; HISTAMINE H2 RECEPTOR ANTAGONIST; IRINOTECAN; LACTOFERRIN; LIPOCALIN; PROTEIN TYROSINE KINASE INHIBITOR; SEMAXANIB; ANGIOGENESIS INHIBITOR; CD24 PROTEIN, HUMAN; INDOLE DERIVATIVE; LEUKOCYTE ANTIGEN; MEMBRANE PROTEIN; PROTEIN TYROSINE KINASE; PYRROLE DERIVATIVE; TUMOR MARKER;

ADULT; ADVANCED CANCER; AGED; ARTICLE; BLOOD SAMPLING; CANCER CHEMOTHERAPY; CLINICAL ARTICLE; CLINICAL TRIAL; COLORECTAL CANCER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISCRIMINANT ANALYSIS; DNA MICROARRAY; DRUG ACTIVITY; FEMALE; GENE EXPRESSION; GENE EXPRESSION PROFILING; HUMAN; HUMAN CELL; MALE; MULTICENTER STUDY; PATIENT CARE; PATIENT CODING; PERIPHERAL BLOOD MONONUCLEAR CELL; PREDICTION; RANDOMIZED CONTROLLED TRIAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; BLOOD; CHEMISTRY; COLORECTAL TUMOR; DRUG ANTAGONISM; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; METASTASIS; METHODOLOGY; MIDDLE AGED; MONONUCLEAR CELL; PHASE 3 CLINICAL TRIAL; PREDICTION AND FORECASTING; VALIDATION STUDY;

AGED; ANGIOGENESIS INHIBITORS; ANTIGENS, CD; ANTIGENS, CD24; CLINICAL TRIALS, PHASE III; COLORECTAL NEOPLASMS; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; INDOLES; LACTOFERRIN; LEUKOCYTES, MONONUCLEAR; MALE; MATRIX METALLOPROTEINASE 9; MEMBRANE GLYCOPROTEINS; MIDDLE AGED; NEOPLASM METASTASIS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PREDICTIVE VALUE OF TESTS; PROTEIN-TYROSINE KINASES; PYRROLES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TUMOR MARKERS, BIOLOGICAL;

EID: 0037423133     PISSN: 14712407     EISSN: None     Source Type: Journal    
DOI: 10.1186/1471-2407-3-3     Document Type: Article

References (31)

1. Brown PO and Botstein D Exploring the new world of the genome with DNA microarrays. Nat Genet 1999, 21:33-37
2. Golub TR, Slonim DK, Tamayo P, Huard C, Gaasenbeek M, Mesirov JP, Coller H, Loh ML, Downing JR, Caligiuri MA, Bloomfield CD and Lander ES Molecular classification of cancer: class discovery and class prediction by gene expression monitoring. Science 1999, 286:531-537
3. Perou CM, Sorlie T, Eisen MB, van de Rijn M, Jeffrey SS, Rees CA, Pollack JR, Ross DT, Johnsen H, Akslen LA, Fluge O, Pergamenschikov A, Williams C, Zhu SX, Lonning PE, Borresen-Dale AL, Brown PO and Botstein D Molecular portraits of human breast tumours. Nature 2000, 406:747-752
4. Alizadeh AA, Eisen MB, Davis RE, Ma C, Lossos IS, Rosenwald A, Boldrick JC, Sabet H, Tran T, Yu X, Powell JI, Yang L, Marti GE, Moore T, Hudson J Jr, Lu L, Lewis DB, Tibshirani R, Sherlock G, Chan WC, Greiner TC, Weisenburger DD, Armitage JO, Warnke R and Staudt LM Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling. Nature 2000, 403:503-511
5. van't Veer LJ, Dai H, van de Vijver MJ, He YD, Hart AA, Mao M, Peterse HL, van der Kooy K, Marton MJ, Witteveen AT, Schreiber GJ, Kerkhoven RM, Roberts C, Linsley PS, Bernards R and Friend SH Gene expression profiling predicts clinical outcome of breast cancer. Nature 2002, 415:530-536
6. Mendel DB, Laird AD, Smolich BD, Blake RA, Liang C, Hannah AL, Shaheen RM, Ellis LM, Weitman S, Shawver LK and Cherrington JM Development of SU a selective small molecule inhibitor of VEGF receptor tyrosine kinase activity, as an anti-angiogenesis agent. Anticancer Drug Des 5416, 15:29-41
7. Shaheen RM, Davis DW, Liu W, Zebrowski BK, Wilson MR, Bucana CD, McConkey DJ, McMahon G and Ellis LM Antiangiogenic therapy targeting the tyrosine kinase receptor for vascular endothelial growth factor receptor inhibits the growth of colon cancer liver metastasis and induces tumor and endothelial cell apoptosis. Cancer Res 1999, 59:5412-5416
8. Lockhart DJ, Dong H, Byrne MC, Follettie MT, Gallo MV, Chee MS, Mittmann M, Wang C, Kobayashi M, Horton H and Brown EL Expression monitoring by hybridization to high-density oligonucleotide arrays. Nat Biotechnol 1996, 14:1675-1680
9. Ramanathan M, Weinstock-Guttman B, Nguyen LT, Badgett D, Miller C, Patrick K, Brownscheidle C and Jacobs L In vivo gene expression revealed by cDNA arrays: the pattern in relapsing-remitting multiple sclerosis patients compared with normal subjects. J Neuroimmunol 2001, 116:213-219
10. Rus V, Atamas SP, Shustova V, Luzina IG, Selaru F, Magder LS and Via CS Expression of cytokine- and chemokine-related genes in peripheral blood mononuclear cells from lupus patients by cDNA array. Clin Immunol 2002, 102:283-290
11. Sawano A, Iwai S, Sakurai Y, Ito M, Shitara K, Nakahata T and Shibuya M Flt-1, vascular endothelial growth factor receptor 1, is a novel cell surface marker for the lineage of monocyte-macrophages in humans. Blood 2001, 97:785-791
12. Selheim F, Holmsen H and Vassbotn FS Identification of functional VEGF receptors on human platelets. FEBS Lett 2002, 512:107-110
13. Rosen PJ, Amado R, Hecht JR, Chang D, Mulay M, Parson M, Laxa B, Brown J, Cropp GF, Hannah A and Rosen L A Phase I/II Study of SU5416 in Combination with 5-FU/Leucovorin in Patients with Metastatic Colorectal Cancer. Proc Am Soc Clin Oncol 2000, 19:3a (abstract 5D)
14. Rothenberg ML, Berlin JD, Cropp GF, Fleischer AC, Schumaker RD, Hande KR, Culley A, Dorminy C, Donnelly E, Chen J, Schaaf L and Hannah AL Phase I/II Study of SU5416 in Combination with Irinotecan/5-FU/LV (IFL) in Patients with Metastatic Colorectal Cancer. Proc Am Soc Clin Oncol 2001, 20:75a (abstract 298)
15. Tripodi D, Lyons S and Davies D Separation of peripheral leukocytes by Ficoll density gradient centrifugation. Transplantation 1971, 11:487-488
16. Chomczynski P A reagent for the single-step simultaneous isolation of RNA, DNA and proteins from cell and tissue samples. Biotechniques 1993, 15:532-534
17. Eberwine J, Yeh H, Miyashiro K, Cao Y, Nair S, Finnell R, Zettel M and Coleman P Analysis of gene expression in single live neurons. Proc Natl Acad Sci U S A 1992, 89:3010-3014
18. Schmittgen TD, Zakrajsek BA, Mills AG, Gorn V, Singer MJ and Reed MW Quantitative reverse transcription-polymerase chain reaction to study mRNA decay: comparison of endpoint and real-time methods. Anal Biochem 2000, 285:194-204
19. Huberty CJ Applied Discriminant Analysis New York: Wiley-Interscience 1994,
20. Nguyen M, Arkell J and Jackson CJ Human endothelial gelatinases and angiogenesis. Int J Biochem Cell Biol 2001, 33:960-970
21. de Fraipont F, Nicholson AC, Feige JJ and Van Meir EG Thrombospondins and tumor angiogenesis. Trends Mol Med 2001, 7:401-407
22. Devireddy LR, Teodoro JG, Richard FA and Green MR Induction of apoptosis by a secreted lipocalin that is transcriptionally regulated by IL-3 deprivation. Science 2001, 293:829-834
23. Schneeberger C, Speiser P, Kury F and Zeillinger R Quantitative detection of reverse transcriptase-PCR products by means of a novel and sensitive DNA stain. PCR Methods Appl 1995, 4:234-238
24. Saltz LB, Cox JV, Blanke C, Rosen LS, Fehrenbacher L, Moore MJ, Maroun JA, Ackland SP, Locker PK, Pirotta N, Elfring GL and Miller LL Irinotecan plus fluorouracil and leucovorin for metastatic colorectal cancer. Irinotecan Study Group. N Engl J Med 2000, 343:905-914
25. Douillard JY, Cunningham D, Roth AD, Navarro M, James RD, Karasek P, Jandik P, Iveson T, Carmichael J, Alakl M, Gruia G, Awad L and Rougier P Irinotecan combined with fluorouracil compared with fluorouracil alone as first-line treatment for metastatic colorectal cancer: a multicentre randomised trial. Lancet 2000, 355:1041-1047
26. Hofmann WK, de Vos S, Elashoff D, Gschaidmeier H, Hoelzer D, Koeffler HP and Ottmann OG Relation between resistance of Philadelphia-chromosome-positive acute lymphoblastic leukaemia to the tyrosine kinase inhibitor STI571 and gene-expression profiles: a gene-expression study. Lancet 2002, 359:481-486
27. Tusher VG, Tibshirani R and Chu G Significance analysis of microarrays applied to the ionizing radiation response. Proc Natl Acad Sci U S A 2001, 98:5116-5121
28. Cowland JB and Borregaard N Molecular characterization and pattern of tissue expression of the gene for neutrophil gelatinase-associated lipocalin from humans. Genomics 1997, 45:17-23
29. Norrby K, Mattsby-Baltzer I, Innocenti M and Tuneberg S Orally administered bovine lactoferrin systemically inhibits VEGF(165)-mediated angiogenesis in the rat. Int J Cancer 2001, 91:236-240
30. Yan L, Borregaard N, Kjeldsen L and Moses MA The high molecular weight urinary matrix metalloproteinase (MMP) activity is a complex of gelatinase B/MMP-9 and neutrophil gelatinase-associated lipocalin (NGAL). Modulation of MMP-9 activity by NGAL. J Biol Chem 2001, 276:37258-37265
31. Rainen L, Oelmueller U, Jurgensen S, Wyrich R, Ballas C, Schram J, Herdman C, Bankaitis-Davis D, Nicholls N, Trollinger D and Tryon V Stabilization of mRNA expression in whole blood samples. Clin Chem 2002, 48:1883-1890